FindTrial
Sign In

To assess the bleeding complications following immunization and its management

A descriptive study to assess the incidence of bleeding complications following immunization and prophylactic measures done to prevent bleeding complications in the patient with hemophilia in Kasturba Hospital, Manipal - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/066207
Enrollment
100
Registered
2024-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D67- Hereditary factor IX deficiency Health Condition 2: D66- Hereditary factor VIII deficiency

Interventions

Control Intervention1: nil: nil

Sponsors

Manipal College of Nursing
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Patients with hemophilia of any age group. • Patients who have received immunizations. • Patients with history of admission to KH, Manipal

Exclusion criteria

Exclusion criteria: i)History of allergic reactions to immunizations. ii) Patients taking anticoagulants. iii) Patients who are unable to provide informed consent

Design outcomes

Primary

MeasureTime frame
Insight on the bleeding complications following immunization in hemophilia patients.Timepoint: 4 weeks to 6 weeks—

Secondary

MeasureTime frame
insight on prophylactic measures to prevent bleeding complications.Timepoint: 24 HOURS—

Countries

India

Contacts

Public ContactSandra Mary Abraham

Manipal College of Nursing

sandra.abraham@learner.manipal.edu8848121106

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026